| Ident. | Authors (with country if any) | Title |
|---|
| 000038 (2020) |
Peter Kranke ; Stephanie Weibel ; Magdalena Sitter ; Patrick Meybohm ; Thierry Girard | [Obstetric Anesthesia During the SARS-CoV-2 Pandemic - a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees]. |
| 000044 (2020) |
Rong-Sheng Luan [République populaire de Chine] ; Xin Wang [République populaire de Chine] ; Xin Sun [République populaire de Chine] ; Xing-Shu Chen [République populaire de Chine] ; Tao Zhou [République populaire de Chine] ; Quan-Hui Liu [République populaire de Chine] ; Xin Lü [République populaire de Chine] ; Xian-Ping Wu [République populaire de Chine] ; Dong-Qing Gu [République populaire de Chine] ; Ming-Shuang Tang [République populaire de Chine] ; Hui-Jie Cui [République populaire de Chine] ; Xue-Feng Shan [République populaire de Chine] ; Jing Ouyang [République populaire de Chine] ; Ben Zhang [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Emergency Research Group Sichuan University Covid- [République populaire de Chine] | [Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review]. |
| 000059 (2020) |
Catrin Sohrabi [Royaume-Uni] ; Zaid Alsafi [Royaume-Uni] ; Niamh O'Neill [Royaume-Uni] ; Mehdi Khan [Royaume-Uni] ; Ahmed Kerwan [Royaume-Uni] ; Ahmed Al-Jabir [Royaume-Uni] ; Christos Iosifidis [Royaume-Uni] ; Riaz Agha [Royaume-Uni] | World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) |
| 000087 (2020) |
Daniel B. Jernigan | Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020. |
| 000099 (2020) |
Yong Xiong [République populaire de Chine] ; Yuan Liu [République populaire de Chine] ; Liu Cao [République populaire de Chine] ; Dehe Wang [République populaire de Chine] ; Ming Guo [République populaire de Chine] ; Ao Jiang [République populaire de Chine] ; Dong Guo [République populaire de Chine] ; Wenjia Hu [République populaire de Chine] ; Jiayi Yang [République populaire de Chine] ; Zhidong Tang [République populaire de Chine] ; Honglong Wu [République populaire de Chine] ; Yongquan Lin [République populaire de Chine] ; Meiyuan Zhang [République populaire de Chine] ; Qi Zhang [République populaire de Chine] ; Mang Shi [République populaire de Chine] ; Yingle Liu [République populaire de Chine] ; Yu Zhou [République populaire de Chine] ; Ke Lan [République populaire de Chine] ; Yu Chen [République populaire de Chine] | Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. |
| 000136 (2020) |
Hussin A. Rothan [États-Unis] ; Siddappa N. Byrareddy [États-Unis] | The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak |
| 000147 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada] | The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. |
| 000148 (2020) |
Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie] | The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 |
| 000155 (2020) |
Wen-Hsiang Chen ; Ulrich Strych ; Peter J. Hotez ; Maria Elena Bottazzi | The SARS-CoV-2 Vaccine Pipeline: an Overview |
| 000179 (2020) |
Pranab Chatterjee [Inde] ; Nazia Nagi [Inde] ; Anup Agarwal [Inde] ; Bhabatosh Das [Inde] ; Sayantan Banerjee [Inde] ; Swarup Sarkar [Inde] ; Nivedita Gupta [Inde] ; Raman R. Gangakhedkar [Inde] | The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence. |
| 000190 (2020) |
Jianzhong Shi [République populaire de Chine] ; Zhiyuan Wen [République populaire de Chine] ; Gongxun Zhong [République populaire de Chine] ; Huanliang Yang [République populaire de Chine] ; Chong Wang [République populaire de Chine] ; Baoying Huang [République populaire de Chine] ; Renqiang Liu [République populaire de Chine] ; Xijun He [République populaire de Chine] ; Lei Shuai [République populaire de Chine] ; Ziruo Sun [République populaire de Chine] ; Yubo Zhao [République populaire de Chine] ; Peipei Liu [République populaire de Chine] ; Libin Liang [République populaire de Chine] ; Pengfei Cui [République populaire de Chine] ; Jinliang Wang [République populaire de Chine] ; Xianfeng Zhang [République populaire de Chine] ; Yuntao Guan [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; Guizhen Wu [République populaire de Chine] ; Hualan Chen [République populaire de Chine] ; Zhigao Bu [République populaire de Chine] | Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. |
| 000230 (2020) |
Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker [États-Unis] ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie] | Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids |
| 000266 (2020) |
Osama M. Al-Quteimat [Émirats arabes unis] ; Amer Mustafa Amer [Jordanie] | SARS-CoV-2 outbreak: How can pharmacists help? |
| 000286 (2020) |
Michele Costanzo ; Maria Anna Rachele De Giglio ; Giovanni Nicola Roviello | SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus. |
| 000330 (2020) |
Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis] | Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status |
| 000347 (2020) |
Leah F. Moriarty ; Mateusz M. Plucinski ; Barbara J. Marston ; Ekaterina V. Kurbatova ; Barbara Knust ; Erin L. Murray ; Nicki Pesik ; Dale Rose ; David Fitter ; Miwako Kobayashi ; Mitsuru Toda ; Paul T. Canty ; Tara Scheuer ; Eric S. Halsey ; Nicole J. Cohen ; Lauren Stockman ; Debra A. Wadford ; Alexandra M. Medley ; Gary Green ; Joanna J. Regan ; Kara Tardivel ; Stefanie White ; Clive Brown ; Christina Morales ; Cynthia Yen ; Beth Wittry ; Amy Freeland ; Sara Naramore ; Ryan T. Novak ; David Daigle ; Michelle Weinberg ; Anna Acosta ; Carolyn Herzig ; Bryan K. Kapella ; Kathleen R. Jacobson ; Katherine Lamba ; Atsuyoshi Ishizumi ; John Sarisky ; Erik Svendsen ; Tricia Blocher ; Christine Wu ; Julia Charles ; Riley Wagner ; Andrea Stewart ; Paul S. Mead ; Elizabeth Kurylo ; Stefanie Campbell ; Rachel Murray ; Paul Weidle ; Martin Cetron ; Cindy R. Friedman | Public Health Responses to COVID-19 Outbreaks on Cruise Ships - Worldwide, February-March 2020. |
| 000376 (2020) |
Syed Faraz Ahmed ; Ahmed A. Quadeer ; Matthew R. Mckay [République populaire de Chine] | Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies |
| 000390 (2020) |
Helen C. Johnson [Suède] ; Céline M. Gossner [Suède] ; Edoardo Colzani [Suède] ; John Kinsman [Suède] ; Leonidas Alexakis [Suède] ; Julien Beauté [Suède] ; Andrea Würz [Suède] ; Svetla Tsolova [Suède] ; Nick Bundle [Suède] ; Karl Ekdahl [Suède] | Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020 |
| 000417 (2020) |
Guangyu Zhou [République populaire de Chine] ; Qi Zhao [République populaire de Chine] | Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 |
| 000445 (2020) |
Robin N. Thompson [Royaume-Uni] | Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations |
| 000454 (2020) |
Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France] | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
